Radiotherapy (RT) Dose-intensification (DI) Using Intensity-modulated RT (IMRT) versus Standard-dose (SD) RT with Temozolomide (TMZ) in Newly Diagnosed Glioblastoma (GBM): Preliminary Results of NRG Oncology BN001
Vinai Gondi, S. Pugh, C. Tsien, Thomas L. Chenevert, Mark R. Gilbert, Antonio Omuro, John E. McDonough, Kenneth Aldape, Ashok Srinivasan, Leland Rogers, Wenjing Shi, James Suh, Özer Algan, Lucien Nedzi, M.D. Chan, J.P. Bahary, Minesh P. Mehta
Topics & Concepts
MedicineTemozolomideHazard ratioConfidence intervalClinical endpointRandomized controlled trialRadiation therapyNuclear medicineInternal medicineGlioblastomaOncologyCancer researchGlioma Diagnosis and TreatmentAdvanced Radiotherapy TechniquesRadiation Therapy and Dosimetry